Radioiodination of internalizing monoclonal antibodies using N- succinimidyl 5-iodo-3-pyridinecarboxylate

Cancer Research

Volumn 56, Issue 21, 1996, Pages 4970-4977

  Reist, Craig J ^a   Garg, Pradeep K ^a,b   Alston, Kevin L ^a   Bigner, Darell D ^a   Zalutsky, Michael R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MONOCLONAL ANTIBODY; N SUCCINIMIDYL 5 IODO 3 PYRIDINECARBOXYLIC ACID; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; GLIOMA; ISOTOPE LABELING; LUNG NON SMALL CELL CANCER; LYSOSOME; MOUSE; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL; RADIOIODINATION; RADIOISOTOPE THERAPY;

3T3 CELLS; ANIMALS; ANTIBODIES, MONOCLONAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; IODINE RADIOISOTOPES; ISOTOPE LABELING; MICE; MICE, INBRED BALB C; RADIOIMMUNODETECTION; RADIOIMMUNOTHERAPY; RECEPTOR, EPIDERMAL GROWTH FACTOR; TISSUE DISTRIBUTION;

EID: 0029961911     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Vitetta, E. S., and Uhr, J. W. Immunotoxins: redirecting nature's poisons. Cell, 41: 653-654, 1985.
2. Wargalla, U. C , and Reisfeld, R. A. Rate of internalization of an immunotoxin correlates with cytotoxic activity against human tumor cells. Proc. Natl. Acad. Sci USA, 86: 5146-5150, 1989.
3. Press, O. W., DeSantes, K., Anderson, S. K , and Geissler, F. Inhibition of catabolism of radiolabeled antibodies by tumor cells using lysosomotropic amines and carboxylic ionophores. Cancer Res, 50, 1243-1250, 1990.
4. Press, O. W., Hansen, J A., Farr, A , and Martin, P J. Endocytosis and degradation of marine anti-human CD3 monoclonal antibodies by normal and malignant T-lymphocytes. Cancer Res , 48: 2249-2257, 1988.
5. Geissler, F., Anderson, S. K., and Press, O. Intracellular catabolism of radiolabeled anti-CD3 antibodies by leukemic T cells Cell Immunol , 137: 96-110, 1991.
6. Press, O W., Farr, A. G., Borroz, K. I , Anderson, S. K , and Martin, P J. Endocytosis and degradation of monoclonal antibodies targeting human B-cell malignancies Cancer Res., 49: 4906-4912, 1989.
7. Press, O. W , Howell-Clark, J., Anderson, S., and Bernstein, I Retention of B-cell-specific monoclonal antibodies by human lymphoma cells. Blood, 83: 1390-1397, 1994
8. Press, O W., Eary, J., Appelbaum, F. R., Badger, C. C., and Bernstein, I. D. Radiolabeled antibody therapy of lymphoma. Cancer Treat. Res., 66: 127-145, 1993.
9. Novak-Hofer, I., Amstutz, H P., Morgenthaler, J. J., and Schubiger, P A. Internalization and degradation of monoclonal antibody chCE7 by human neuroblastoma cells. Int. J. Cancer, 57: 427-432, 1994.
10. Slamon, D J., Godolphin, W., Jones, L. A., Holt. J A , Wong, S G., Keith, D. E , Levin, W. J., Stuart, S G , Udove, J , Ullrich, A., and Press, M. F. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer Science (Washington DC), 244 707-712, 1989.
11. Wikstrand, C. J , Hale, L. P , Batra, S K , Hill, M. L , Humphrey, P. A., Kurpad, S N., McLendon, R E., Moscatello, D., Pegram, C. N., Reist, C J., Traweek, S. T., Wong, A. J , Zlautsky, M. R., and Bigner, D. D. Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas. Cancer Res., 55: 3140-3148, 1995.
12. Moscatello, D. K , Holgado-Madruga, M., Godwin, A. K , Ramirez, G., Gunn, G., Zoltick, P. W., Biegel, J. A., Hayes, R. L., and Wong, A J. Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors. Cancer Res., 55: 5536-5539, 1995
13. Pittman, R C., Carew, T E., Glass, C. K., Green, S R., Taylor, C A., Jr., and Attie, A. D. A radioiodinated, intracellularly trapped ligand for determining the sites of plasma protein degradation in vivo Biochem. J, 212: 791-800, 1983.
14. Ali, S A., Warren, S D., Richter, K. Y , Badger, C C , Eary, J. F., Press, O. W., Krohn, K A , Bernstein, I. D. and Nelp, W. B. Improving the tumor retention of radioiodinated antibody, aryl carbohydrate adducts Cancer Res., 50 (Suppl.): 783s-788s, 1990.
15. 125I-tyramine, an improved residualizing label for studies on sites of catabolism of circulating proteins. J Biol. Chem , 263: 14122-14127, 1988.
16. Thorpe, S. R , Baynes, J W., and Chroneos, Z C. The design and application of residualizing labels for studies of protein catabolism FASEB J., 7: 399-405, 1993.
17. Reist, C J , Archer, G E., Kurpad, S. N., Wikstrand, C J., Vaidyanathan, G., Willingham, M. C., Moscatello, D K., Wong, A J., Bigner, D. D., and Zalutsky, M. R Tumor-specific anti-epidermal growth factor receptor variant III monoclonal antibodies: use of the tyramine-cellobiose radioiodination method enhances cellular retention and uptake in tumor xenografts Cancer Res., 55: 4375-4382, 1995.
18. Glass, C K., Pittman, R C , Keller, G. A , and Steinberg, D. Tissue sites of degradation of appoprotein A-1 in the rat J. Biol. Chem., 258: 7161-7167, 1983.
19. Moerlein, S. M., Dalal, K. B., Ebbe, S. N., Yano, Y., and Budinger, T. F. Residualizing and non-residualizing analogues of low-density lipoprotein as iodine-123 radiopharmaceuticals for imaging LDL catabolism Nucl. Med Biol., 15, 141-149, 1988
20. Ali, S. A., Eary, J. F., Warren, S. D , Badger, C. C , and Krohn, K. A. Synthesis and radioiodination of tyramine cellobiose for labeling monoclonal antibodies Int. J. Radiat. Appl. Instrum. B , 15: 557-561, 1988.
21. Schilling, U., Friedrich, E. A , Sinn, H., Schrenk, H. H., Clonus, J. H , and Maier-Borst, W. Design of compounds having enhanced tumor uptake, using serum albumin as a carrier-Part II. In vivo studies. Nucl. Med. Biol., 19: 685-695, 1992.
22. Holtzman, E. Lysosomes, pp 95-100. New York: Plenum Press, 1989
23. Garg, S., Garg, P. K., and Zalutsky, M. R N-succinimidyl 5-(trialkylstannyl)-3-pyridine-carboxylates: a new class of reagents for protein radioiodination Bioconjugate Chem , 2: 50-56, 1991.
24. Garg, S., Garg, P. K., Zhao, X. G., Friedman, H. S , Bigner, D. D., and Zalutsky, M. R. Radioiodination of a monoclonal antibody using N-succinimidyl 5-iodo-3-pyridinecarboxylate. Nucl. Med. Biol., 20: 835-842, 1993.
25. Yamazaki, H., Ohba, Y , Tamaoki, N., and Shibuya, M. A deletion mutation within the ligand binding domain is responsible for activation of epidermal growth factor receptor gene in human brain tumors. Jpn. J. Cancer Res., 81: 773-779, 1990.
26. Batra, S. K., Castelino-Prabhu, S., Wikstrand, C. J., Zhu, X., Humphrey, P. A , Friedman, H S., and Bigner, D. D. Epidermal growth factor ligand-independent. unregulated, cell-transforming potential of a naturally occurring human mutant EGFRvIII gene. Cell Growth & Differ., 6: 1251-1259, 1995.
27. Fraker, P. J., and Speck, J. C., Jr. Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3α,6α-diphrenylglycoluril. Biochem. Biophys. Res Commun., 80 849-857, 1978.
28. Garg, P. K., Archer, G. E., Jr., Bigner, D. D , and Zalutsky, M. R. Synthesis of radioiodinated N-succinimidyl iodobenzoate optimization for use in antibody labelling. Int J. Rad. Appl. Instrum., 40: 485-490, 1989.
29. 2 fragment labeled using N-succinimidyl 3-iodobenzoate and iodogen methods. Bioconjugate Chem , 6: 493-501, 1995.
30. Lindmo, T., Boven, E., Cuttitta, F., Fedorko, J., and Bunn, P A., Jr Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. J Immunol Methods, 72, 77-89, 1984.
31. McPherson, G. A. A practical computer based approach to the analysis of radioligand binding experiments Comput. Programs Biomed., 17: 107-113, 1983.
32. Ohkuma, S., and Poole, B. Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. Proc. Natl. Acad. Sci. USA, 75: 3327-3331, 1996.
33. Amartey, J. K , and Wolf, W. The hexachlorotechnetate reagent in the synthesis, characterization and biodistribution of two novel lipophilic complexes. Nucl Med Biol., 18: 797-802, 1991
34. Ekstrand, A. J., Sugawa, N., James, C D., and Collins, V. P. Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails. Proc Natl. Acad Sci. USA, 89: 4309-4313, 1992.
35. Wong, A. J., Ruppert, J. M., Bigner, S. H , Grzeschik, C. H., Humphrey, P. A., Bigner. D. S., and Vogelstein, B. Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proc. Natl. Acad. Sci. USA., 89: 2965-2969, 1992.
36. Geissler, F., Anderson, S. K., Venkatesan, P , and Press, O. Intracellular catabolism of radiolabeled anti-μ antibodies by malignant B-cells. Cancer Res., 52: 2907-2915, 1992
37. Franssen, E J., Koiter, J., Kuipers, C A., Bruins, A P , Moolenaar, F , de Zeeu, D, Kruizinga, W. H., Kellogg, R. M., and Meijer, D. K. Low molecular weight proteins as carriers for renal drug targeting Preparation of drug-protein conjugates and drug-spacer derivatives and their catabolism in renal cortex homogenates and lysosomal lysates. J. Med. Chem., 35: 1246-1259, 1992
38. Duncan, J R., and Welch, M. J. Intracellular metabolism of indium-111-DTPA-labeled receptor targeted proteins. J Nucl. Med , 34: 1728-1738, 1993.
39. Arano, Y., Mukai, T , Akizawa, H., Uezono, T., Montonari, H , Wakisaka, K., Kairiyama, C , and Yokoyama, A Radiolabeled metabolites of proteins play a critical role in radioactivity elimination from the liver. Nucl. Med. Biol., 22: 555-564, 1995.
40. 111In-diethylenetriammepentaacetic acid-monoclonal antibodies and antibody fragments in vivo. Cancer Res, 55 (Suppl.): 5714s-5720s, 1995.
41. Morrison, R T , and Boyd, R. N. Organic Chemistry, p. 1082. Boston, MA: Allyn and Bacon, Inc., 1966.
42. Maack, T., Park, C. H., and Camargo, M J Filtration, transport, and metabolism of proteins. In: D. W. Seldin and G Giebisch (eds.), The Kidney: Physiology and Pathophysiology, pp. 3005-3038. New York Raven Press, 1992
43. 111In-DPTA-e-lysine as the primary metabolic and excretory product. Nucl. Med. Biol., 21: 1023-1034, 1994.
44. Franano, F. N , Edwards, W. B., Welch, M. J., Brechbiel, M W , Gansow, O. A , and Duncan, J. R. Biodistribution and metabolism of targeted and nontargeted protein-chelate-gadolinium complexes, evidence for gadolinium dissociation in vitro and in vivo. Magn. Reson Imaging, 13: 201-214, 1995.
45. Cheeseman, C. I., King, I., and Smith, M. W Tissue distribution of exogenous amino acids during transport across the vascular perfused anuran small intestine. J. Physiol., 339: 133-144, 1983.